Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.005 per share
-
Shares outstanding
-
110,002,045
-
Total 13F shares
-
994,393
-
Share change
-
+272,071
-
Total reported value
-
$292,358
-
Price per share
-
$0.29
-
Number of holders
-
24
-
Value change
-
+$69,709
-
Number of buys
-
8
-
Number of sells
-
8
Institutional Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) as of Q4 2024
As of 31 Dec 2024,
Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
994,393 shares.
The largest 10 holders included
Corient Private Wealth LLC, GEODE CAPITAL MANAGEMENT, LLC, Cypress Point Wealth Management, LLC, XTX Topco Ltd, Sippican Capital Advisors, Naviter Wealth, LLC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA SECURITIES, LLC, and VANGUARD GROUP INC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.